SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601830-23-000056
Filing Date
2023-08-08
Accepted
2023-08-08 08:03:03
Documents
108
Period of Report
2023-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxrx-20230808.htm   iXBRL 8-K 25054
2 EX-99.1 exhibit991-q0223.htm EX-99.1 103438
3 EX-99.2 exhibit992-q0223.htm EX-99.2 16446
4 EX-99.3 rxrxq2_finalxwebsite.htm EX-99.3 102971
8 pipelineq22023a.jpg GRAPHIC 146275
9 rxrxq2_finalxwebsite001.jpg GRAPHIC 213942
10 rxrxq2_finalxwebsite002.jpg GRAPHIC 241034
11 rxrxq2_finalxwebsite003.jpg GRAPHIC 70712
12 rxrxq2_finalxwebsite004.jpg GRAPHIC 155173
13 rxrxq2_finalxwebsite005.jpg GRAPHIC 127858
14 rxrxq2_finalxwebsite006.jpg GRAPHIC 210234
15 rxrxq2_finalxwebsite007.jpg GRAPHIC 86138
16 rxrxq2_finalxwebsite008.jpg GRAPHIC 106280
17 rxrxq2_finalxwebsite009.jpg GRAPHIC 78320
18 rxrxq2_finalxwebsite010.jpg GRAPHIC 108205
19 rxrxq2_finalxwebsite011.jpg GRAPHIC 98682
20 rxrxq2_finalxwebsite012.jpg GRAPHIC 136154
21 rxrxq2_finalxwebsite013.jpg GRAPHIC 113377
22 rxrxq2_finalxwebsite014.jpg GRAPHIC 228046
23 rxrxq2_finalxwebsite015.jpg GRAPHIC 107355
24 rxrxq2_finalxwebsite016.jpg GRAPHIC 106295
25 rxrxq2_finalxwebsite017.jpg GRAPHIC 124355
26 rxrxq2_finalxwebsite018.jpg GRAPHIC 103271
27 rxrxq2_finalxwebsite019.jpg GRAPHIC 110933
28 rxrxq2_finalxwebsite020.jpg GRAPHIC 102401
29 rxrxq2_finalxwebsite021.jpg GRAPHIC 96743
30 rxrxq2_finalxwebsite022.jpg GRAPHIC 218174
31 rxrxq2_finalxwebsite023.jpg GRAPHIC 80651
32 rxrxq2_finalxwebsite024.jpg GRAPHIC 98711
33 rxrxq2_finalxwebsite025.jpg GRAPHIC 102147
34 rxrxq2_finalxwebsite026.jpg GRAPHIC 132834
35 rxrxq2_finalxwebsite027.jpg GRAPHIC 116424
36 rxrxq2_finalxwebsite028.jpg GRAPHIC 128514
37 rxrxq2_finalxwebsite029.jpg GRAPHIC 98618
38 rxrxq2_finalxwebsite030.jpg GRAPHIC 109936
39 rxrxq2_finalxwebsite031.jpg GRAPHIC 127592
40 rxrxq2_finalxwebsite032.jpg GRAPHIC 95408
41 rxrxq2_finalxwebsite033.jpg GRAPHIC 123533
42 rxrxq2_finalxwebsite034.jpg GRAPHIC 86284
43 rxrxq2_finalxwebsite035.jpg GRAPHIC 105236
44 rxrxq2_finalxwebsite036.jpg GRAPHIC 106024
45 rxrxq2_finalxwebsite037.jpg GRAPHIC 119691
46 rxrxq2_finalxwebsite038.jpg GRAPHIC 100647
47 rxrxq2_finalxwebsite039.jpg GRAPHIC 117647
48 rxrxq2_finalxwebsite040.jpg GRAPHIC 88264
49 rxrxq2_finalxwebsite041.jpg GRAPHIC 96721
50 rxrxq2_finalxwebsite042.jpg GRAPHIC 87366
51 rxrxq2_finalxwebsite043.jpg GRAPHIC 109407
52 rxrxq2_finalxwebsite044.jpg GRAPHIC 89125
53 rxrxq2_finalxwebsite045.jpg GRAPHIC 98407
54 rxrxq2_finalxwebsite046.jpg GRAPHIC 96304
55 rxrxq2_finalxwebsite047.jpg GRAPHIC 118274
56 rxrxq2_finalxwebsite048.jpg GRAPHIC 90728
57 rxrxq2_finalxwebsite049.jpg GRAPHIC 109516
58 rxrxq2_finalxwebsite050.jpg GRAPHIC 90274
59 rxrxq2_finalxwebsite051.jpg GRAPHIC 99989
60 rxrxq2_finalxwebsite052.jpg GRAPHIC 94606
61 rxrxq2_finalxwebsite053.jpg GRAPHIC 96360
62 rxrxq2_finalxwebsite054.jpg GRAPHIC 106927
63 rxrxq2_finalxwebsite055.jpg GRAPHIC 94833
64 rxrxq2_finalxwebsite056.jpg GRAPHIC 124497
65 rxrxq2_finalxwebsite057.jpg GRAPHIC 105591
66 rxrxq2_finalxwebsite058.jpg GRAPHIC 105801
67 rxrxq2_finalxwebsite059.jpg GRAPHIC 80041
68 rxrxq2_finalxwebsite060.jpg GRAPHIC 120849
69 rxrxq2_finalxwebsite061.jpg GRAPHIC 99773
70 rxrxq2_finalxwebsite062.jpg GRAPHIC 85309
71 rxrxq2_finalxwebsite063.jpg GRAPHIC 125649
72 rxrxq2_finalxwebsite064.jpg GRAPHIC 108332
73 rxrxq2_finalxwebsite065.jpg GRAPHIC 111591
74 rxrxq2_finalxwebsite066.jpg GRAPHIC 107966
75 rxrxq2_finalxwebsite067.jpg GRAPHIC 104351
76 rxrxq2_finalxwebsite068.jpg GRAPHIC 104363
77 rxrxq2_finalxwebsite069.jpg GRAPHIC 93134
78 rxrxq2_finalxwebsite070.jpg GRAPHIC 87950
79 rxrxq2_finalxwebsite071.jpg GRAPHIC 118668
80 rxrxq2_finalxwebsite072.jpg GRAPHIC 87351
81 rxrxq2_finalxwebsite073.jpg GRAPHIC 136137
82 rxrxq2_finalxwebsite074.jpg GRAPHIC 79704
83 rxrxq2_finalxwebsite075.jpg GRAPHIC 114300
84 rxrxq2_finalxwebsite076.jpg GRAPHIC 211366
85 rxrxq2_finalxwebsite077.jpg GRAPHIC 108836
86 rxrxq2_finalxwebsite078.jpg GRAPHIC 130894
87 rxrxq2_finalxwebsite079.jpg GRAPHIC 148761
88 rxrxq2_finalxwebsite080.jpg GRAPHIC 120748
89 rxrxq2_finalxwebsite081.jpg GRAPHIC 211328
90 rxrxq2_finalxwebsite082.jpg GRAPHIC 92794
91 rxrxq2_finalxwebsite083.jpg GRAPHIC 140187
92 rxrxq2_finalxwebsite084.jpg GRAPHIC 142886
93 rxrxq2_finalxwebsite085.jpg GRAPHIC 150886
94 rxrxq2_finalxwebsite086.jpg GRAPHIC 119340
95 rxrxq2_finalxwebsite087.jpg GRAPHIC 102459
96 rxrxq2_finalxwebsite088.jpg GRAPHIC 98323
97 rxrxq2_finalxwebsite089.jpg GRAPHIC 97052
98 rxrxq2_finalxwebsite090.jpg GRAPHIC 138751
99 rxrxq2_finalxwebsite091.jpg GRAPHIC 113351
100 rxrxq2_finalxwebsite092.jpg GRAPHIC 77335
  Complete submission text file 0001601830-23-000056.txt   15336012

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20230808.xsd EX-101.SCH 1907
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20230808_lab.xml EX-101.LAB 23834
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20230808_pre.xml EX-101.PRE 12512
102 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20230808_htm.xml XML 2746
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 231149414
SIC: 2836 Biological Products, (No Diagnostic Substances)